Multiple Myeloma

Multiple Myeloma

A collection of features and news articles published in ASH Clinical News related to multiple myeloma.

Controversies in Myeloma: The Who, When, and Why of Treatment

The recent expansion of treatment options for patients with multiple myeloma (MM) has introduced new opportunities for redefining the goals of therapy. At the...

Previous Malignancy May Increase Risk of Subsequent Malignancy in Patients With Myeloma

A number of new treatments for patients with multiple myeloma (MM) have become available in recent years, enabling patients to live longer. Unfortunately, these...
WIB_icon

Early Phase Study of Selinexor With and Without Dexamethasone for Patients With Myeloma and...

According to results of a phase I study published in Blood, treatment with the XPO1 inhibitor selinexor and dexamethasone led to half of patients...

How I Treat in Brief: New Agents in Myeloma

This month, Philippe Moreau, MD, discusses the changing landscape of multiple myeloma (MM) therapeutics and options for treatment in frontline and relapsed settings. This material...

The Ins and Outs of Inclusion Criteria for Myeloma Clinical Trials

Clinical trial protocols often incorporate strict eligibility criteria to maximize reproducible, results with minimal risk to trial participants. Unfortunately, restricting a trial’s patient population...

Is MRD Testing Worthwhile in Myeloma?

With the clinically effective treatment regimens now available for myeloma, more patients can achieve deep and sustained responses. The ability to measure minimal residual...

Order Matters: The Art and Science of Myeloma Drug Sequencing

Examining the who, what, when, where, and why of myeloma treatment In 1844, Thomas Alexander Bean, one of the first documented patients with multiple myeloma...
Advertisement

Current Issue

May 2019, Volume 5, Issue 6

This issue features a look at home-based care for hematologic disorders, strides in pediatric leukemia in El Salvador, and more.